Traub Capital Management’s Chemours CC Stock Holding History

Traub Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-860	Closed	-$9.85K	–	201
2025 Q2	$9.85K	Buy	+860	New	+$9.69K	0.01%	389

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Traub Capital Management's CC Position: Q3 2025 in Review

Traub Capital Management sold out of Chemours (CC) in Q3 2025, closing a stake of 860 shares — an estimated $9.85K sold.

Traub Capital Management first reported a position in CC in Q2 2025 and held it in 1 quarter. The position peaked at $9.85K in Q2 2025. 428 funds tracked by Wall St. Rank hold CC as of Q3 2025.

Traub Capital Management reported no remaining Chemours position as of Q3 2025 after selling out during the quarter.
Traub Capital Management sold 860 Chemours shares in Q3 2025, an estimated $9.85K.
Traub Capital Management first reported a position in Chemours in Q2 2025 and held it in 1 quarter.
Traub Capital Management's Chemours position peaked at $9.85K in Q2 2025.
428 funds tracked by Wall St. Rank held Chemours as of Q3 2025.

Based on Traub Capital Management's 13F filing for Q3 2025, filed 30 Oct 2025.